Where Does Wall Street Think Solid Biosciences Inc (SLDB) Stock Will Go?

InvestorsObserver is giving Solid Biosciences Inc (SLDB) an Analyst Rating Rank of 26, meaning SLDB is ranked higher by analysts than 26% of stocks. The average price target for SLDB is $6.75 and analyst’s rate the stock as a Buy.

Wall Street analysts are rating SLDB a Buy today. Find out what this means to you and get the rest of the rankings on SLDB!

See Full SLDB Report

Why are Analyst Ratings Important?

You can learn a lot about a company from looking at it’s financial statements and comparing them to other companies. Analysts who cover an industry in depth can add even more to your research though. They typically follow a particular sector or industry very closely. They also pay attention to and ask questions on earnings conference calls and other events where they might learn information that does show up in the numbers. InvestorsObserver takes the average rating from these analysts, and then percentile ranks those averages. This lets you compare stocks in a much more granular way than just seeing the typical five-tiered rating system used on most of Wall Street.

What's Happening With Solid Biosciences Inc Stock Today?

Solid Biosciences Inc (SLDB) stock is trading at $2.70 as of 10:00 AM on Friday, Nov 24, a gain of $0.08, or 3.05% from the previous closing price of $2.62. The stock has traded between $2.63 and $2.78 so far today. Volume today is low. So far 21,750 shares have traded compared to average volume of 538,726 shares. Click Here to get the full Stock Report for Solid Biosciences Inc stock.